Craig-Hallum analyst Matt Hewitt maintained a Buy rating on HealthStream (HSTM – Research Report) today. The company’s shares closed yesterday at $22.46.
According to TipRanks, Hewitt is an analyst with an average return of -3.8% and a 35.65% success rate. Hewitt covers the Healthcare sector, focusing on stocks such as Apyx Medical, Repligen, and HealthStream.
HealthStream has an analyst consensus of Moderate Buy, with a price target consensus of $22.00.
See the top stocks recommended by analysts >>
Based on HealthStream’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $69.2 million and a net profit of $4.13 million. In comparison, last year the company earned a revenue of $65.64 million and had a net profit of $3.08 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HealthStream (HSTM) Company Description:
HealthStream, Inc. engages in the provision of services to healthcare organizations and other members within the healthcare industry. It operates through the following segments: Workforce Solutions and Provider Solutions. The Workforce Solutions segment offers talent management, training, certification, competency assessment, and performance appraisal services. The Provider Solutions consists of credentialing, privileging, call center, and enrollment products and services. The company was founded by Robert A. Frist, Jr. and Jeffery L. McLaren in 1990 and is headquartered in Nashville, TN.
Read More on HSTM:
